Published in
Nature Research, Nature Medicine, 11(27), p. 1904-1909, 2021
DOI: 10.1038/s41591-021-01562-9
Links
Tools
Dalpiciclib or placebo plus fulvestrant in hormone receptor-positive and HER2-negative advanced breast cancer: a randomized, phase 3 trial
Journal article published in 2021 by
Binghe Xu 
,
Qingyuan Zhang,
Pin Zhang,
Xichun Hu,
Wei Li,
Zhongsheng Tong,
Tao Sun,
Yuee Teng,
Xinhong Wu,
Quchang Ouyang,
Xi Yan,
Jing Cheng,
Qiang Liu,
Jifeng Feng,
Xiaojia Wang
and other authors.
,
Qingyuan Zhang,
Pin Zhang,
Xichun Hu,
Wei Li,
Zhongsheng Tong,
Tao Sun,
Yuee Teng,
Xinhong Wu,
Quchang Ouyang,
Xi Yan,
Jing Cheng,
Qiang Liu,
Jifeng Feng,
Xiaojia Wang
and other authors.
This paper is made freely available by the publisher.
Full text: Download
Published version:
archiving forbidden
Data provided by 